The first FibroGen trade was made in Q3 2015.
Since then Paul Tudor Jones II bought shares ten more times and sold shares on fourteen occasions. The investor completely sold their stake between Q2 2023 and Q1 2024.
Avg closing price
Price range
Sold -48.2 Thousand shares
Q1 2024
Avg closing price
$1.72
Price range
$0.73
-
$2.73
Sold 1.0% shares (-495 shares)
Q3 2023
Avg closing price
$1.57
Price range
$0.79
-
$2.83
Sold 2.6% shares (-1.32 Thousand shares)
Q2 2023
Avg closing price
$16.54
Price range
$2.49
-
$20.59
New holding (+50 Thousand shares)
Q1 2023
Avg closing price
$21.16
Price range
$15.95
-
$25.18
Sold -126 Thousand shares
Q3 2022
Avg closing price
$12.88
Price range
$11.40
-
$14.60
Sold 4.9% shares (-6.47 Thousand shares)
Q2 2022
Avg closing price
$10.22
Price range
$7.94
-
$12.96
New holding (+132 Thousand shares)
Q1 2022
Avg closing price
$13.94
Price range
$12.02
-
$16.79
Sold -63.1 Thousand shares
Q4 2021
Avg closing price
$12.45
Price range
$9.93
-
$15.39
Increased shares by 127.4% (+35.4 Thousand shares)
Q3 2021
Avg closing price
$14.17
Price range
$10.18
-
$26.64
New holding (+27.7 Thousand shares)
Q2 2021
Avg closing price
$23.04
Price range
$18.57
-
$35.68
Sold -10.7 Thousand shares
Q3 2020
Avg closing price
$43.04
Price range
$40.47
-
$45.50
New holding (+10.7 Thousand shares)
Q2 2020
Avg closing price
$37.14
Price range
$32.57
-
$42.83
Sold -7.27 Thousand shares
Q4 2019
Avg closing price
$40.84
Price range
$34.58
-
$48.06
New holding (+7.27 Thousand shares)
Q3 2019
Avg closing price
$43.93
Price range
$36.98
-
$48.45
Sold -12.3 Thousand shares
Q1 2018
Avg closing price
$52.68
Price range
$45.35
-
$61.65
Sold 28.2% shares (-4.81 Thousand shares)
Q4 2017
Avg closing price
$50.16
Price range
$41.95
-
$60.10
Increased shares by 41.1% (+4.98 Thousand shares)
Q3 2017